Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure

European Heart Journal: Acute Cardiovascular Care

Volumn 9, Issue 2, 2020, Pages 138-148

  Sieweke, Jan Thorben ^a   Berliner, Dominik ^a   Tongers, Jörn ^a   Napp, L Christian ^a   Flierl, Ulrike ^a   Zauner, Florian ^a   Bauersachs, Johann ^a   Schäfer, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

acute heart failure; Cardiogenic shock; STEMI; ventricular assist device

Indexed keywords

CATECHOLAMINE; LEVOSIMENDAN;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD PRESSURE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART ARREST; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; REGISTER; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 85164548421     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872618757393     Document Type: Article

References (25)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625–634.
2. Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: A multidisciplinary practical guidance. Intensive Care Med 2016; 42: 147–163.
3. Schwarz B, Abdel-Wahab M, Robinson DR, et al. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation. Med Klin Intensivmed Notfmed 2016; 111: 715–722.
4. Thiele H, Zeymer U, Werdan K., Intraaortic balloon support for cardiogenic shock. N Engl J Med 2013; 368: 81.
5. Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 2015; 17: 501–509.
6. Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541–2619.
7. Bangalore S, Gupta N, Guo Y, et al. Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 2015; 128: 601–608.
8. Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638–1645.
9. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.
10. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362–e425.
11. Mebazaa A, Yilmaz MB, Levy P, et al. Recommendations on pre-hospital and early hospital management of acute heart failure: A consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine – short version. Eur Heart J 2015; 36: 1958–1966.
12. Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: Practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 2016; 18: 1096–1105.
13. O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study. Circulation 2012; 126: 1717–1727.
14. O’Neill WW, Schreiber T, Wohns DH, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: Results from the USpella Registry. J Interv Cardiol 2014; 27: 1–11.
15. Basir MB, Schreiber TL, Grines CL, et al. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 2017; 119: 845–851.
16. Ouweneel DM, Eriksen E, Sjauw KD, et al. Impella CP versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: The IMPRESS trial. J Am Coll Cardiol 2017; 69: 278–287.
17. Poss J, Koster J, Fuernau G, et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69: 1913–1920.
18. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 2007; 297: 1883–1891.
19. Lin YH, Huang HC, Chang YC, et al. Multi-scale symbolic entropy analysis provides prognostic prediction in patients receiving extracorporeal life support. Crit Care 2014; 18: 548.
20. Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452–2483.
21. DanShock Investigatorerne. [Treatment of cardiogenic shock with percutanous mechanical circulatory support]. Ugeskr Laeger 2013; 175: 205–208.
22. Ostadal P, Rokyta R, Kruger A, et al. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): Rationale and design of the multicenter randomized trial. Eur J Heart Fail 2017; 19(Suppl. 2): 124–127.
23. Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2017; 39(2): 119–177.
24. Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017; 377(25): 2419–2432.
25. Zeymer U, Thiele H., Mechanical support for cardiogenic shock: Lost in translation? J Am Coll Cardiol 2017; 69: 288–290.